Is Kratom Legal in Maine? State Law and Shipping Guide

What Maine law says about kratom

Maine defines a scheduled drug as a drug named or described in Title 17-A, section 1102, within Schedule W, X, Y, or Z. Those four schedules are the starting point for determining whether the Maine Criminal Code treats a substance as a scheduled drug. The current schedules identify many substances by name, family, chemical structure, or legal category. They do not identify kratom, Mitragyna speciosa, mitragynine, or 7-hydroxymitragynine.

That conclusion rests on more than a search for the word kratom. Section 1102 contains the full statutory schedules used for Maine drug crimes, while section 1101 supplies the operative definitions. The current Schedule W narcotic-drug provision lists heroin, methadone, opium, morphine, oxycodone, hydrocodone, buprenorphine, fentanyl compounds, and other named substances. Mitragynine is not included in that provision. The remaining schedules likewise do not name the kratom plant or its principal alkaloids.

Maine's legislative record provides an additional confirmation. LD 1546 was introduced in 2017 to revise Schedule W and expressly proposed adding mitragynine. The Legislature did not enact that portion. The adopted majority amendment struck the original substance list and specifically stated that it removed mitragynine and phenylpiperazine from the proposed additions. The resulting law addressed fentanyl-related compounds without placing mitragynine in Schedule W.

The distinction matters because an introduced bill is not the same as enacted law. The original text of LD 1546 shows that Maine lawmakers considered naming mitragynine. The adopted amendment and current statute show that the proposed addition did not become part of Maine's drug schedule. Later sessions through the July 21, 2026 review date did not produce an enacted statewide kratom prohibition or a kratom-specific consumer protection act.

General product and label rules still apply

The absence of a kratom-specific prohibition does not create an exemption from Maine's ordinary product laws. Title 22, section 2157 treats food as misbranded when its labeling is false or misleading. Packaged products generally must identify the manufacturer, packer, or distributor and accurately state the quantity of the contents by weight, measure, or numerical count. Required label information must be displayed conspicuously enough to be read and understood under ordinary purchasing conditions.

Section 2157 also requires the common or usual name of a food and, for products made from two or more ingredients, the common or usual name of each ingredient subject to stated exceptions. These general standards support straightforward ingredient declarations and accurate package quantities for powders, capsules, tablets, and other packaged formats.

Maine law also addresses poisonous or deleterious substances added to food. Section 2158 treats such an added substance as unsafe unless it is required in production or cannot be avoided through good manufacturing practice, subject to any limits adopted by the Commissioner of Agriculture, Conservation and Forestry. A product does not become acceptable merely because its main botanical ingredient is lawful.

Maine has not enacted a kratom-specific statewide minimum purchase age as of the review date. That is different from saying that every product, seller, or transaction is free from all age-related or federal considerations. It means the cited Maine statutes do not impose the kind of 18-plus or 21-plus kratom rule found in several other states.

How Maine's statewide position developed

• May 2017LD 1546 was introduced with language that would have added mitragynine to Maine's Schedule W drugs.
• June 2017The majority committee amendment removed mitragynine from the proposed Schedule W additions and replaced the bill's substance list with fentanyl-related provisions.
• 2017 onwardThe enacted version changed Maine law without scheduling mitragynine, and the current statutory schedules continue to omit kratom and its principal alkaloids.
• 2025-2026 sessionA review of the 132nd Legislature's bill and enacted-law text found no enacted statewide measure placing kratom or mitragynine in Maine's drug schedules or creating a kratom-specific retail prohibition.
• July 21, 2026Traditional kratom remains available under Maine's current statewide law, subject to generally applicable product requirements.

The 2017 history is especially useful because it prevents a common legal-status error. Reading only the introduced version of LD 1546 would produce the wrong answer. The introduced bill proposed scheduling mitragynine, but the Legislature amended that language out before enactment. Maine's present statute reflects the amended outcome, not the discarded proposal.

Maine's Legislature also maintains a searchable archive of bill and enacted-law text. Searching the later legislative record for kratom and mitragynine did not reveal a subsequent enacted measure reversing the 2017 outcome. That record was reviewed together with the codified statutes, rather than used as a substitute for them.

Future legislation could change Maine's position by adding an alkaloid to a controlled-drug schedule, establishing product limits, creating an age requirement, or adopting a broader consumer-protection framework. A bill would need to complete the legislative process and reach its effective date before it changes the current statewide answer.

Powder, capsules, extracts, tablets, and bulk formats

Maine's current statewide law does not divide ordinary kratom products into separate legal categories based solely on whether they are sold as powder, capsules, tablets, or botanical extracts. The relevant legal distinction is whether the contents themselves violate a controlled-substance rule or another applicable product law.

• Whole or crushed leaf: legal statewide under the current Maine schedules when the product is otherwise compliant.
• Loose kratom powder: legal statewide, with ordinary package-quantity and truthful-label expectations still applying.
• Kratom capsules: legal statewide; placing powder in capsules does not change the status of the underlying botanical.
• Botanical extracts and MIT products: not categorically prohibited by Maine's current kratom law, but composition, ingredient accuracy, contamination, and federal status remain important.
• Tablets: the physical tablet format does not by itself create a statewide prohibition.
• Bulk products: lawful product status does not change merely because a larger quantity is ordered, although the label and quantity statement should accurately describe what is supplied.

Lawful status should not be confused with a guarantee about every product sold under a kratom-related name. A mislabeled mixture, a product containing an independently controlled substance, or a package with false quantity or ingredient information can violate other laws even when traditional kratom itself is not scheduled.

The product actually delivered should match its label and listing. For a single-ingredient powder, the identity and net weight should be clear. For capsules or flavored tablets containing multiple ingredients, the ingredient statement should accurately describe the formulation. For extracts, quantitative information should not imply a concentration or composition that the product does not possess.

Kratom shipping to Maine from Las Vegas

Kratom Paradise currently accepts eligible orders for delivery throughout Maine. The estimated Priority Mail arrival is one to two business days after carrier acceptance. This is a delivery estimate rather than a guarantee; weekends, holidays, weather, transportation conditions, address corrections, and carrier processing can affect the final arrival date.

Maine's cited statewide statutes do not establish a kratom-specific carrier permit, adult-signature mandate, or remote-sale identification procedure. The state also does not impose a kratom-specific statewide minimum age in the reviewed provisions. A seller should nevertheless ensure that the exact item shipped remains eligible and that its package accurately identifies its contents and quantity.

The same statewide status applies whether a customer selects powder, capsules, an eligible extract, tablets, or a bulk format. Shipping availability should be reevaluated if Maine later enacts a product-specific restriction or adds kratom alkaloids to a controlled-drug schedule.

Carrier timing begins after acceptance, not when an order is first placed. Orders submitted after a fulfillment cutoff, during a weekend, or before a holiday may require additional handling time before the carrier's estimated transit period begins.

Official Maine sources reviewed

• Maine Revised Statutes, Title 17-A, section 1102
  The current complete statutory schedules W, X, Y, and Z.
• Maine Revised Statutes, Title 17-A, section 1101
  Definitions used in Maine's scheduled-drug chapter.
• LD 1546 original bill text
  The 2017 proposal that initially included mitragynine among proposed Schedule W additions.
• LD 1546 committee amendment S-262
  The adopted amendment that expressly removed mitragynine from the proposed additions.
• Maine Revised Statutes, Title 22, section 2157
  General Maine requirements concerning misbranded food, package identity, quantity, and ingredients.
• Maine Revised Statutes, Title 22, section 2158
  General treatment of added poisonous or deleterious substances in food.
• Maine bill and enacted-law text search
  The Legislature's official searchable record used to review later legislative activity.

Last reviewed: Verified July 21, 2026. Statewide information only; not legal advice.